Indeed, we found the PRNP-CTNNB1-NR3C1 score to be higher in CRC tumors of the CMS4 subtype, those with a pejorative CMS combination, or those associated with a higher risk of relapse based on TNM staging. This evidence concerns the gene PRNP and colorectal carcinoma.